share_log

Context Therapeutics Q1 EPS $(0.23) Beats $(0.38) Estimate

Context Therapeutics Q1 EPS $(0.23) Beats $(0.38) Estimate

Context Therapeutics第一季度每股收益美元(0.23美元)超過預期(0.38美元)
Benzinga ·  05/08 18:00

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.38) by 39.47 percent. This is a 42.5 percent increase over losses of $(0.40) per share from the same period last year.

Context Therapeutics(納斯達克股票代碼:CNTX)公佈的季度虧損爲每股0.23美元,比分析師普遍預期的0.38美元(0.38美元)高出39.47%。這比去年同期每股虧損0.40美元(0.40)增長了42.5%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論